Yet another CRO giant has taken a revenue hit due to a customer demand dip. Irish clinical research organization Icon reported third-quarter revenue of $2.03 billion, underperforming analyst ...
Clinical research organization ICON plc (NASDAQ:ICLR) stock is surging on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2025 sales ...
DUBLIN - Clinical research organization ICON plc (NASDAQ:ICLR), a $14 billion market cap company with "GREAT" financial health according to InvestingPro metrics, announced Thursday that Barry Balfe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results